157 related articles for article (PubMed ID: 22118409)
1. Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease.
Daniel C; von Boehmer H
Adv Immunol; 2011; 112():177-213. PubMed ID: 22118409
[TBL] [Abstract][Full Text] [Related]
2. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
3. Extra-thymically induced regulatory T cells: do they have potential in disease prevention?
Daniel C; von Boehmer H
Semin Immunol; 2011 Dec; 23(6):410-7. PubMed ID: 21724411
[TBL] [Abstract][Full Text] [Related]
4. Thymic and peripheral differentiation of regulatory T cells.
Lee HM; Bautista JL; Hsieh CS
Adv Immunol; 2011; 112():25-71. PubMed ID: 22118406
[TBL] [Abstract][Full Text] [Related]
5. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
Kornete M; Piccirillo CA
Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
[TBL] [Abstract][Full Text] [Related]
6. Prevention of autoimmune gastritis in mice requires extra-thymic T-cell deletion and suppression by regulatory T cells.
Read S; Hogan TV; Zwar TD; Gleeson PA; Van Driel IR
Gastroenterology; 2007 Aug; 133(2):547-58. PubMed ID: 17603058
[TBL] [Abstract][Full Text] [Related]
7. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
8. Impaired T cell receptor signaling in Foxp3+ CD4 T cells.
Carson BD; Ziegler SF
Ann N Y Acad Sci; 2007 Apr; 1103():167-78. PubMed ID: 17376831
[TBL] [Abstract][Full Text] [Related]
9. Peripherally induced Treg: mode, stability, and role in specific tolerance.
Apostolou I; Verginis P; Kretschmer K; Polansky J; Hühn J; von Boehmer H
J Clin Immunol; 2008 Nov; 28(6):619-24. PubMed ID: 18841451
[TBL] [Abstract][Full Text] [Related]
10. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells.
Aschenbrenner K; D'Cruz LM; Vollmann EH; Hinterberger M; Emmerich J; Swee LK; Rolink A; Klein L
Nat Immunol; 2007 Apr; 8(4):351-8. PubMed ID: 17322887
[TBL] [Abstract][Full Text] [Related]
11. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function.
Tanaka S; Maeda S; Hashimoto M; Fujimori C; Ito Y; Teradaira S; Hirota K; Yoshitomi H; Katakai T; Shimizu A; Nomura T; Sakaguchi N; Sakaguchi S
J Immunol; 2010 Aug; 185(4):2295-305. PubMed ID: 20644168
[TBL] [Abstract][Full Text] [Related]
12. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity.
Tarbell KV; Yamazaki S; Steinman RM
Semin Immunol; 2006 Apr; 18(2):93-102. PubMed ID: 16469503
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
14. Treg vaccination in autoimmune type 1 diabetes.
Serr I; Weigmann B; Franke RK; Daniel C
BioDrugs; 2014 Feb; 28(1):7-16. PubMed ID: 23959795
[TBL] [Abstract][Full Text] [Related]
15. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease.
Sgouroudis E; Piccirillo CA
Diabetes Metab Res Rev; 2009 Mar; 25(3):208-18. PubMed ID: 19214972
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 control over Foxp3+ regulatory T cell function.
Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.
Filippi C; Bresson D; von Herrath M
Int Rev Immunol; 2005; 24(5-6):341-60. PubMed ID: 16318986
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells and immune tolerance.
Sakaguchi S; Yamaguchi T; Nomura T; Ono M
Cell; 2008 May; 133(5):775-87. PubMed ID: 18510923
[TBL] [Abstract][Full Text] [Related]
19. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells.
Fujimoto M; Nakano M; Terabe F; Kawahata H; Ohkawara T; Han Y; Ripley B; Serada S; Nishikawa T; Kimura A; Nomura S; Kishimoto T; Naka T
J Immunol; 2011 Jan; 186(1):32-40. PubMed ID: 21106853
[TBL] [Abstract][Full Text] [Related]
20. Expanding and converting regulatory T cells: a horizon for immunotherapy.
Khattar M; Chen W; Stepkowski SM
Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
